CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Subscription Receivables	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2023	$ 4	$ 381,264	$ (60,710)	$ (473,602)	$ (153,044)
Balance at beginning (in shares) at Dec. 31, 2023	516,404
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)					13,936
Balance at the ending at Mar. 31, 2024	$ 4	393,235		(591,620)	$ (198,381)
Balance at ending (in shares) at Mar. 31, 2024	529,778
Balance at the beginning at Dec. 31, 2023	$ 4	381,264	(60,710)	(473,602)	(153,044)
Balance at beginning (in shares) at Dec. 31, 2023	516,404
Net Income (Loss)				46,094	46,094
Termination of Forward Purchase Agreements			$ 60,710		60,710
Issuance of shares and reclassification of liability related to cashless warrant exercises		14,979			$ 14,979
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	27,310				27,310
Stock-based compensation expense		3,314			$ 3,314
Balance at the ending at Jun. 30, 2024	$ 4	399,557		(427,508)	(27,947)
Balance at ending (in shares) at Jun. 30, 2024	543,714
Balance at the beginning at Mar. 31, 2024	$ 4	393,235		(591,620)	(198,381)
Balance at beginning (in shares) at Mar. 31, 2024	529,778
Net Income (Loss)				164,112	164,112
Issuance of shares and reclassification of liability related to cashless warrant exercises		4,629			4,629
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	13,936
Stock-based compensation expense		1,693			1,693
Balance at the ending at Jun. 30, 2024	$ 4	399,557		(427,508)	(27,947)
Balance at ending (in shares) at Jun. 30, 2024	543,714
Balance at the beginning at Dec. 31, 2024	$ 4	403,024		(431,597)	$ (28,569)
Balance at beginning (in shares) at Dec. 31, 2024	555,511				555,511
Net Income (Loss)				2,453	$ 2,453
Issuance of shares and reclassification of liability related to cashless warrant exercises	$ 5	6,864			6,869
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	10,869,856
Issuance of shares related to at-the-market offering, net		84			84
Issuance of shares related to at-the-market offering, net (in shares)	112,503
Stock-based compensation expense		3,311			3,311
Balance at the ending at Jun. 30, 2025	$ 9	413,283		(429,144)	$ (15,852)
Balance at ending (in shares) at Jun. 30, 2025	11,537,870				11,537,870
Balance at the beginning at Mar. 31, 2025	$ 9	411,170		(422,502)	$ (11,323)
Balance at beginning (in shares) at Mar. 31, 2025	10,538,615
Net Income (Loss)				(6,642)	(6,642)
Issuance of shares and reclassification of liability related to cashless warrant exercises		446			446
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	886,752
Issuance of shares related to at-the-market offering, net		84			84
Issuance of shares related to at-the-market offering, net (in shares)	112,503
Stock-based compensation expense		1,583			1,583
Balance at the ending at Jun. 30, 2025	$ 9	$ 413,283		$ (429,144)	$ (15,852)
Balance at ending (in shares) at Jun. 30, 2025	11,537,870				11,537,870